About Us

CardioVere strives to improve the patient journey. Precise intervention improves patient care, and impacts caregivers, mortality, readmissions, length of stay, and cost.

Our Mission

CardioVere’s mission is to provide precise measurement of peripheral edema and change the standard of care for Heart Failure.

Reduce Readmissions

Improve Outcomes

Lower Cost of Care

Our Expertise

CardioVere’s parent company, ChemImage is a pioneer in Molecular Chemical Imaging (MCI). We have extensive experience in advanced surgical imaging and are the first company formed to bring MCI to materials analysis. As the only company with this level of expertise, we have been able to develop complex biological detection for healthcare optimization.

ChemImage-developed patents protect this peripheral edema monitoring device that will be highly differentiated and first to market.  Patents are available for exclusive license under defined field of use.  To learn more about ChemImage, visit us at chemimage.com.

Our Team

Mike Chappuis

Business Lead Consultant

Dr. Matthew Nelson

Chief Technology Officer

Lew Lanker

Senior Product Manager

Dr. Richik Ghosh

Director of Program Management

Beth Ezar

Director of Marketing & Business Development

Gary Pruden

Business Advisor

Aileen Stockburger

Business Advisor

Seeking Partnership Opportunities with Global MedTech Leaders